Biomarkers in malignant pleural mesothelioma: current status and future directions

被引：16
作者：
Ahmadzada, Tamkin [1 ]
Reid, Glen [1 ,2 ]
Kao, Steven [2 ,3 ]
机构：
[1] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[2] ADRI, Sydney, NSW, Australia
[3] Chris OBrien Lifehouse, Dept Med Oncol, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
DETECT ASBESTOS EXPOSURE; OPEN-LABEL; DIAGNOSIS; PROGNOSIS; TRIAL; OSTEOPONTIN; EXPRESSION; FIBULIN-3; HMGB1;
D O I：
10.21037/jtd.2018.04.31
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S1003 / S1007
页数：5
相关论文
共 50 条
[31]   Emerging biological therapies for the treatment of malignant pleural mesothelioma [J].
Davis, Alexander P. ;
Kao, Steven C. ;
Clarke, Stephen J. ;
Boyer, Michael ;
Pavlakis, Nick .
EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (02) :179-192
[32]   Tamoxifen Suppresses the Growth of Malignant Pleural Mesothelioma Cells [J].
Jennings, Cormac J. ;
Zainal, Najihah ;
Dahlan, Izyan M. M. ;
Kay, Elaine W. ;
Harvey, Brian J. ;
Thomas, Warren .
ANTICANCER RESEARCH, 2016, 36 (11) :5905-5913
[33]   Immunotherapy approaches for malignant pleural mesothelioma [J].
Fennell, Dean A. ;
Dulloo, Sean ;
Harber, James .
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (09) :573-584
[34]   Malignant Pleural Mesothelioma: an Update for Pulmonologists [J].
Sidhu, Calvinjit ;
Louw, Amber ;
Brims, Fraser ;
Creaney, Jenette ;
Lee, Y. C. Gary .
CURRENT PULMONOLOGY REPORTS, 2019, 8 (02) :40-49
[35]   Malignant Pleural Mesothelioma: A Comprehensive Review [J].
Jain, Molly ;
Crites, Morgan Kay ;
Rich, Patricia ;
Bajantri, Bharat .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
[36]   Perspectives on the Treatment of Malignant Pleural Mesothelioma [J].
Janes, Sam M. ;
Alrifai, Doraid ;
Fennell, Dean A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (13) :1207-1218
[37]   Is there a role for immunotherapy in malignant pleural mesothelioma? [J].
Tartarone, Alfredo ;
Lerose, Rosa ;
Aieta, Michele .
MEDICAL ONCOLOGY, 2018, 35 (07)
[38]   Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma [J].
Carmina Jiménez-Ramírez ;
Swaantje Casjens ;
Cuauhtémoc Arturo Juárez-Pérez ;
Irina Raiko ;
Luz M. Del Razo ;
Dirk Taeger ;
Emma S. Calderón-Aranda ;
Hans-Peter Rihs ;
Leonor Concepción Acosta-Saavedra ;
Daniel Gilbert Weber ;
Alejandro Cabello-López ;
Beate Pesch ;
María Dolores Ochoa-Vázquez ;
Katarzyna Burek ;
Luis Torre-Bouscoulet ;
José Rogelio Pérez-Padilla ;
Erik Marco García-Bazan ;
Thomas Brüning ;
Georg Johnen ;
Guadalupe Aguilar-Madrid .
Lung, 2019, 197 :641-649
[39]   Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm [J].
Sayan, Mutlay ;
Eren, Mehmet Fuat ;
Gupta, Apar ;
Ohri, Nisha ;
Kotek, Ayse ;
Babalioglu, Ibrahim ;
Kaplan, Sedenay Oskeroglu ;
Duran, Ozge ;
Or, Ozlem Derinalp ;
Cukurcayie, Funda ;
Kurtul, Neslihan ;
Bicakci, Beyhan Ceylaner ;
Kutuk, Tugce ;
Senyurek, Sukran ;
Turk, Ali ;
Jabbour, Salma K. ;
Atalar, Banu .
ADVANCES IN RESPIRATORY MEDICINE, 2019, 87 (05) :289-297
[40]   Surgical Options for Management of Malignant Pleural Mesothelioma in the Current Era [J].
Loubani, Mahmoud ;
Qadri, Syed S. ;
Hussain, Azar ;
Chaudhry, Mubarak A. ;
Kastelik, Jack A. .
CURRENT RESPIRATORY MEDICINE REVIEWS, 2016, 12 (04) :286-293
12345